Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-24-095931

President and CEO acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2024-11-07 Grant or award +45,000 1,826,098 D
Loading xslF345X05/ownership.xml…